Global Human Oral Vaccine Market Research Report 2023

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The global Human Oral Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Human Oral Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Human Oral Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Human Oral Vaccine include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Oral Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Oral Vaccine.

The Human Oral Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Oral Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Oral Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Human Oral Vaccine

1.2 Human Oral Vaccine Segment by Type

1.2.1 Global Human Oral Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Rotavirus Vaccine

1.2.3 Cholera Vaccine

1.2.4 Oral Polio Vaccine

1.2.5 Other

1.3 Human Oral Vaccine Segment by Application

1.3.1 Global Human Oral Vaccine Market Value by Application: (2023-2029)

1.3.2 Public

1.3.3 Private

1.4 Global Human Oral Vaccine Market Size Estimates and Forecasts

1.4.1 Global Human Oral Vaccine Revenue 2018-2029

1.4.2 Global Human Oral Vaccine Sales 2018-2029

1.4.3 Global Human Oral Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Human Oral Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Human Oral Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Human Oral Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Human Oral Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Human Oral Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Oral Vaccine, Product Type & Application

2.7 Human Oral Vaccine Market Competitive Situation and Trends

2.7.1 Human Oral Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Human Oral Vaccine Players Market Share by Revenue

2.7.3 Global Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Human Oral Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Human Oral Vaccine Global Human Oral Vaccine Sales by Region: 2018-2029

3.2.1 Global Human Oral Vaccine Sales by Region: 2018-2023

3.2.2 Global Human Oral Vaccine Sales by Region: 2024-2029

3.3 Global Human Oral Vaccine Global Human Oral Vaccine Revenue by Region: 2018-2029

3.3.1 Global Human Oral Vaccine Revenue by Region: 2018-2023

3.3.2 Global Human Oral Vaccine Revenue by Region: 2024-2029

3.4 North America Human Oral Vaccine Market Facts & Figures by Country

3.4.1 North America Human Oral Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Human Oral Vaccine Sales by Country (2018-2029)

3.4.3 North America Human Oral Vaccine Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Oral Vaccine Market Facts & Figures by Country

3.5.1 Europe Human Oral Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Human Oral Vaccine Sales by Country (2018-2029)

3.5.3 Europe Human Oral Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Oral Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Human Oral Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Human Oral Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Human Oral Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Human Oral Vaccine Market Facts & Figures by Country

3.7.1 Latin America Human Oral Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Human Oral Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Human Oral Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Oral Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Oral Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Human Oral Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Human Oral Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Human Oral Vaccine Sales by Type (2018-2029)

4.1.1 Global Human Oral Vaccine Sales by Type (2018-2023)

4.1.2 Global Human Oral Vaccine Sales by Type (2024-2029)

4.1.3 Global Human Oral Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Human Oral Vaccine Revenue by Type (2018-2029)

4.2.1 Global Human Oral Vaccine Revenue by Type (2018-2023)

4.2.2 Global Human Oral Vaccine Revenue by Type (2024-2029)

4.2.3 Global Human Oral Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Human Oral Vaccine Price by Type (2018-2029)

5.1 Global Human Oral Vaccine Sales by Application (2018-2029)

5.1.1 Global Human Oral Vaccine Sales by Application (2018-2023)

5.1.2 Global Human Oral Vaccine Sales by Application (2024-2029)

5.1.3 Global Human Oral Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Human Oral Vaccine Revenue by Application (2018-2029)

5.2.1 Global Human Oral Vaccine Revenue by Application (2018-2023)

5.2.2 Global Human Oral Vaccine Revenue by Application (2024-2029)

5.2.3 Global Human Oral Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Human Oral Vaccine Price by Application (2018-2029)

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Merck Human Oral Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 GSK Human Oral Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Sanofi Human Oral Vaccine Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Lanzhou Institute

6.4.1 Lanzhou Institute Corporation Information

6.4.2 Lanzhou Institute Description and Business Overview

6.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Lanzhou Institute Human Oral Vaccine Product Portfolio

6.4.5 Lanzhou Institute Recent Developments/Updates

6.5 Serum Institute

6.5.1 Serum Institute Corporation Information

6.5.2 Serum Institute Description and Business Overview

6.5.3 Serum Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Serum Institute Human Oral Vaccine Product Portfolio

6.5.5 Serum Institute Recent Developments/Updates

6.6 Valneva

6.6.1 Valneva Corporation Information

6.6.2 Valneva Description and Business Overview

6.6.3 Valneva Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Valneva Human Oral Vaccine Product Portfolio

6.6.5 Valneva Recent Developments/Updates

6.7 Shanghai United Cell

6.6.1 Shanghai United Cell Corporation Information

6.6.2 Shanghai United Cell Description and Business Overview

6.6.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Shanghai United Cell Human Oral Vaccine Product Portfolio

6.7.5 Shanghai United Cell Recent Developments/Updates

6.8 Bibcol

6.8.1 Bibcol Corporation Information

6.8.2 Bibcol Description and Business Overview

6.8.3 Bibcol Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Bibcol Human Oral Vaccine Product Portfolio

6.8.5 Bibcol Recent Developments/Updates

6.9 PaxVax

6.9.1 PaxVax Corporation Information

6.9.2 PaxVax Description and Business Overview

6.9.3 PaxVax Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 PaxVax Human Oral Vaccine Product Portfolio

6.9.5 PaxVax Recent Developments/Updates

6.10 Vabiotech

6.10.1 Vabiotech Corporation Information

6.10.2 Vabiotech Description and Business Overview

6.10.3 Vabiotech Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Vabiotech Human Oral Vaccine Product Portfolio

6.10.5 Vabiotech Recent Developments/Updates

6.11 Tiantan Biological

6.11.1 Tiantan Biological Corporation Information

6.11.2 Tiantan Biological Human Oral Vaccine Description and Business Overview

6.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Tiantan Biological Human Oral Vaccine Product Portfolio

6.11.5 Tiantan Biological Recent Developments/Updates

6.12 EuBiologics

6.12.1 EuBiologics Corporation Information

6.12.2 EuBiologics Human Oral Vaccine Description and Business Overview

6.12.3 EuBiologics Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.12.4 EuBiologics Human Oral Vaccine Product Portfolio

6.12.5 EuBiologics Recent Developments/Updates

6.13 Panacea Biotec Ltd

6.13.1 Panacea Biotec Ltd Corporation Information

6.13.2 Panacea Biotec Ltd Human Oral Vaccine Description and Business Overview

6.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Panacea Biotec Ltd Human Oral Vaccine Product Portfolio

6.13.5 Panacea Biotec Ltd Recent Developments/Updates

6.14 Bio-Med

6.14.1 Bio-Med Corporation Information

6.14.2 Bio-Med Human Oral Vaccine Description and Business Overview

6.14.3 Bio-Med Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Bio-Med Human Oral Vaccine Product Portfolio

6.14.5 Bio-Med Recent Developments/Updates

6.15 Halfkin Bio-Pharmaceuticals

6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information

6.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Description and Business Overview

6.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolio

6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7.1 Human Oral Vaccine Industry Chain Analysis

7.2 Human Oral Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Oral Vaccine Production Mode & Process

7.4 Human Oral Vaccine Sales and Marketing

7.4.1 Human Oral Vaccine Sales Channels

7.4.2 Human Oral Vaccine Distributors

7.5 Human Oral Vaccine Customers

8.1 Human Oral Vaccine Industry Trends

8.2 Human Oral Vaccine Market Drivers

8.3 Human Oral Vaccine Market Challenges

8.4 Human Oral Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Human Oral Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Human Oral Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Human Oral Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Human Oral Vaccine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Human Oral Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Human Oral Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Human Oral Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Human Oral Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Human Oral Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Human Oral Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Human Oral Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Human Oral Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Human Oral Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Human Oral Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Human Oral Vaccine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Human Oral Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Human Oral Vaccine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Human Oral Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Human Oral Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Human Oral Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Human Oral Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Human Oral Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Human Oral Vaccine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Human Oral Vaccine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Human Oral Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Human Oral Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Human Oral Vaccine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Human Oral Vaccine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Human Oral Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Human Oral Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Human Oral Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Human Oral Vaccine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Human Oral Vaccine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Human Oral Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Human Oral Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Human Oral Vaccine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Human Oral Vaccine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Human Oral Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Human Oral Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Human Oral Vaccine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Human Oral Vaccine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Human Oral Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Human Oral Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Human Oral Vaccine Sales (K Units) by Type (2018-2023)

    Table 51. Global Human Oral Vaccine Sales (K Units) by Type (2024-2029)

    Table 52. Global Human Oral Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Human Oral Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Human Oral Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Human Oral Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Human Oral Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Human Oral Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Human Oral Vaccine Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Human Oral Vaccine Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Human Oral Vaccine Sales (K Units) by Application (2018-2023)

    Table 61. Global Human Oral Vaccine Sales (K Units) by Application (2024-2029)

    Table 62. Global Human Oral Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Human Oral Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Human Oral Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Human Oral Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Human Oral Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Human Oral Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Human Oral Vaccine Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Human Oral Vaccine Price (US$/Unit) by Application (2024-2029)

    Table 70. Merck Corporation Information

    Table 71. Merck Description and Business Overview

    Table 72. Merck Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Merck Human Oral Vaccine Product

    Table 74. Merck Recent Developments/Updates

    Table 75. GSK Corporation Information

    Table 76. GSK Description and Business Overview

    Table 77. GSK Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. GSK Human Oral Vaccine Product

    Table 79. GSK Recent Developments/Updates

    Table 80. Sanofi Corporation Information

    Table 81. Sanofi Description and Business Overview

    Table 82. Sanofi Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Sanofi Human Oral Vaccine Product

    Table 84. Sanofi Recent Developments/Updates

    Table 85. Lanzhou Institute Corporation Information

    Table 86. Lanzhou Institute Description and Business Overview

    Table 87. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Lanzhou Institute Human Oral Vaccine Product

    Table 89. Lanzhou Institute Recent Developments/Updates

    Table 90. Serum Institute Corporation Information

    Table 91. Serum Institute Description and Business Overview

    Table 92. Serum Institute Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Serum Institute Human Oral Vaccine Product

    Table 94. Serum Institute Recent Developments/Updates

    Table 95. Valneva Corporation Information

    Table 96. Valneva Description and Business Overview

    Table 97. Valneva Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Valneva Human Oral Vaccine Product

    Table 99. Valneva Recent Developments/Updates

    Table 100. Shanghai United Cell Corporation Information

    Table 101. Shanghai United Cell Description and Business Overview

    Table 102. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Shanghai United Cell Human Oral Vaccine Product

    Table 104. Shanghai United Cell Recent Developments/Updates

    Table 105. Bibcol Corporation Information

    Table 106. Bibcol Description and Business Overview

    Table 107. Bibcol Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Bibcol Human Oral Vaccine Product

    Table 109. Bibcol Recent Developments/Updates

    Table 110. PaxVax Corporation Information

    Table 111. PaxVax Description and Business Overview

    Table 112. PaxVax Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. PaxVax Human Oral Vaccine Product

    Table 114. PaxVax Recent Developments/Updates

    Table 115. Vabiotech Corporation Information

    Table 116. Vabiotech Description and Business Overview

    Table 117. Vabiotech Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Vabiotech Human Oral Vaccine Product

    Table 119. Vabiotech Recent Developments/Updates

    Table 120. Tiantan Biological Corporation Information

    Table 121. Tiantan Biological Description and Business Overview

    Table 122. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Tiantan Biological Human Oral Vaccine Product

    Table 124. Tiantan Biological Recent Developments/Updates

    Table 125. EuBiologics Corporation Information

    Table 126. EuBiologics Description and Business Overview

    Table 127. EuBiologics Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. EuBiologics Human Oral Vaccine Product

    Table 129. EuBiologics Recent Developments/Updates

    Table 130. Panacea Biotec Ltd Corporation Information

    Table 131. Panacea Biotec Ltd Description and Business Overview

    Table 132. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 133. Panacea Biotec Ltd Human Oral Vaccine Product

    Table 134. Panacea Biotec Ltd Recent Developments/Updates

    Table 135. Bio-Med Corporation Information

    Table 136. Bio-Med Description and Business Overview

    Table 137. Bio-Med Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 138. Bio-Med Human Oral Vaccine Product

    Table 139. Bio-Med Recent Developments/Updates

    Table 140. Halfkin Bio-Pharmaceuticals Corporation Information

    Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview

    Table 142. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 143. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product

    Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates

    Table 145. Key Raw Materials Lists

    Table 146. Raw Materials Key Suppliers Lists

    Table 147. Human Oral Vaccine Distributors List

    Table 148. Human Oral Vaccine Customers List

    Table 149. Human Oral Vaccine Market Trends

    Table 150. Human Oral Vaccine Market Drivers

    Table 151. Human Oral Vaccine Market Challenges

    Table 152. Human Oral Vaccine Market Restraints

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Human Oral Vaccine

    Figure 2. Global Human Oral Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Human Oral Vaccine Market Share by Type in 2022 & 2029

    Figure 4. Rotavirus Vaccine Product Picture

    Figure 5. Cholera Vaccine Product Picture

    Figure 6. Oral Polio Vaccine Product Picture

    Figure 7. Other Product Picture

    Figure 8. Global Human Oral Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Human Oral Vaccine Market Share by Application in 2022 & 2029

    Figure 10. Public

    Figure 11. Private

    Figure 12. Global Human Oral Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Human Oral Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Human Oral Vaccine Sales (2018-2029) & (K Units)

    Figure 15. Global Human Oral Vaccine Average Price (US$/Unit) & (2018-2029)

    Figure 16. Human Oral Vaccine Report Years Considered

    Figure 17. Human Oral Vaccine Sales Share by Manufacturers in 2022

    Figure 18. Global Human Oral Vaccine Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Human Oral Vaccine Players: Market Share by Revenue in 2022

    Figure 20. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Human Oral Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Human Oral Vaccine Sales Market Share by Country (2018-2029)

    Figure 23. North America Human Oral Vaccine Revenue Market Share by Country (2018-2029)

    Figure 24. United States Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Human Oral Vaccine Sales Market Share by Country (2018-2029)

    Figure 27. Europe Human Oral Vaccine Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Human Oral Vaccine Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Human Oral Vaccine Revenue Market Share by Region (2018-2029)

    Figure 35. China Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. China Taiwan Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Human Oral Vaccine Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Human Oral Vaccine Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. UAE Human Oral Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Human Oral Vaccine by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Human Oral Vaccine by Type (2018-2029)

    Figure 56. Global Human Oral Vaccine Price (US$/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Human Oral Vaccine by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Human Oral Vaccine by Application (2018-2029)

    Figure 59. Global Human Oral Vaccine Price (US$/Unit) by Application (2018-2029)

    Figure 60. Human Oral Vaccine Value Chain

    Figure 61. Human Oral Vaccine Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed